From 2017 to 2022, we reached 530 million people with medical innovations in over 95 countries. Our agreements are strengthening healthcare markets and making products more affordable and available.

Learn more about our health impact ⤵️

medaccess.org/why-we-exist/o…

🆕 Join our team! We are looking for an Impact Associate to join our Health Markets team.

Reporting to the Head of Impact, you will support our impact evaluations and assessments, monitor executed deals and review our Impact Framework.

Apply by 2 June ➡️ medaccess.org/careers/

We are pleased to hear today's announcement from Department of Health and Social Care & GSK of £130m to tackle growing #AntimicrobialResistance .

Rather than developing new antibiotics, the funding will improve access to existing drugs and ensure they are used more effectively.

ft.com/content/6249ee…

🙌 Good news! TAK-003 is the second #dengue vaccine prequalified by World Health Organization (WHO).

It is estimated that dengue will cause 40,000 deaths this year, double those seen in 2000. A new vaccine is a much needed addition to the suite of prevention methods.

who.int/news/item/15-0…

Every year, 1.2 million people die of drug-resistant infections. We must reduce use of #antibiotics , strengthen surveillance, and support development of new drugs to mitigate this global health challenge.

#AMR | #AntimicrobialResistance

theguardian.com/global-develop…

.World Health Organization (WHO) certified Belize 🇧🇿, Jamaica 🇯🇲 and St. Vincent & the Grenadines 🇻🇨 for eliminating mother-to-child transmission of HIV & syphilis.

Our volume guarantee for SD BIOSENSOR's dual HIV/syphilis test supports global elimination efforts by ⬆️ testing.

paho.org/en/stories/mak…

#Dengue is spreading as the planet warms. Estimated deaths this year (40,000) will be double those seen in 2000 (20,000). Prevention initiatives will need to be rolled out in greater volumes and in more places as a result of #ClimateChange .

economist.com/leaders/2024/0…

🆕 We are hiring! We are looking for an Impact Associate to join our team.

Reporting to the Head of Impact, you will support our impact evaluations and assessments, monitor executed deals and review our Impact Framework.

Apply by 2 June ➡️ medaccess.org/careers/

'Across various countries, vaccination programs have proven to generate substantial value, outweighing their costs multiple times over.'

A good read on the value of immunisation programmes by POLITICO.

politico.eu/sponsored-cont…

🆕 We are delighted to welcome Cyrus Ardalan to our Board of Directors where he will join other experts from the fields of finance and health to oversee the governance of the company.

medaccess.org/medaccess-welc…

📅 EVENT: We are looking forward to the 2024 Industry Engagement 'Access to Health Innovation' Forum next week.

Kaodili Udeh will speak in Session 4: Financing the health products value chain in Africa.

Government of Nigeria | African Development Bank Group | IFC | Unitaid

afdb.org/en/news-and-ev…

There are promising efforts underway to develop the world's first #TB vaccine in more than 100 years. At the end of 2023, there were 16 TB vaccines in development, four of which were in phase 3 clinical trials.

Vox | #EndTB | #YesWeCanEndTB

vox.com/future-perfect…

Read the April edition of our newsletter: Access Matters!

▶️ New support from Foreign, Commonwealth & Development Office
▶️ Surge financing for medical countermeasures
▶️ Progress on the RTS,S #malaria vaccine and New Nets Project.

#MarketShaping #InnovativeFinance #AccessToMedicine

linkedin.com/pulse/uk-impro…

We are pleased to have worked alongside a dedicated group of partners on expanding access to BASF Agricultural Solutions's Interceptor G2 mosquito nets to prevent #malaria . Learn more in this story.

Gates Foundation | The Global Fund | @Unitaid | IVCC

thinkglobalhealth.org/article/how-in…

Thank you David Cameron and Rt Hon Andrew Mitchell MP for leading Foreign, Commonwealth & Development Office to support access to medicines through MedAccess. With capital from British International Investment this funding will translate directly into affordable treatments for malaria, HIV, and TB

🦟 Back in 2021, the RTS,S #malaria vaccine faced a halt in manufacturing. An agreement between MedAccess, @Gavi & GSK paved the way for continued production.

Since then, over 2M children have been vaccinated.

#HumanlyPossible | #WorldImmunizationWeek

medaccess.org/our-agreements…

Congratulations Benin, Liberia and Sierra Leone for launching large-scale rollouts of the world’s first malaria vaccine targeting millions of children! bit.ly/3UAAnIN #WorldMalariaDay

World Health Organization (WHO), UNICEF, GSK, Unitaid, The Global Fund, MedAccess, @PATHTweets, USAID Global Health